Suppr超能文献

使用碳纤维椎间融合器治疗颈椎病神经根病。

Use of carbon fiber cages for treatment of cervical myeloradiculopathies.

作者信息

Tancredi Angelo, Agrillo Antonino, Delfini Roberto, Fiume Dario, Frati Alessandro, Rinaldi Alessandro

机构信息

Department of Neurosurgery, San Filippo Neri Hospital, Rome, USA.

出版信息

Surg Neurol. 2004 Mar;61(3):221-6; discussion 226. doi: 10.1016/j.surneu.2003.07.014.

Abstract

BACKGROUND

Different types of intersomatic fixation systems are available for use in the treatment of cervical disc pathologies. In this paper, we report our experience using carbon fiber cages (Brantigan I/F cage, De Puy Acromed, Raynham, MA; Mikai distrib.) for acute and chronic cervical disc pathologies.

METHODS

Between 1997 and 2001, 97 patients underwent surgical treatment for cervical disc pathologies. Follow-up ranged from 1 to 60 months. In all cases a microdiscectomy according to Caspar was performed; anterior stabilization was performed in cases with evidence of instability and in post-traumatic disc herniations.

RESULTS

A total number of 119 carbon fiber cages, ranging in height from 4 to 8 mm, were employed as well as 10 anterior plates with screws. The type of material used to fill the cages was homologous bone (50.5%), heterologous bone (22.3%), hydroxyapatite (21.1%), and autologous bone (6%). In all cases, follow-up radiograms performed after at least 6 months demonstrated bone fusion. None of the patients had either spontaneous displacement of the implant or symptoms from nerve compression.

CONCLUSIONS

These preliminary results suggest that anterior cervical fusion with carbon fiber cages are valid to restore intervertebral disc height and to promote bone fusion with low complications rate.

摘要

背景

有不同类型的椎间融合固定系统可用于治疗颈椎间盘病变。在本文中,我们报告了使用碳纤维椎间融合器(Brantigan I/F椎间融合器,De Puy Acromed公司,美国马萨诸塞州雷纳姆;由Mikai公司经销)治疗急慢性颈椎间盘病变的经验。

方法

1997年至2001年期间,97例患者接受了颈椎间盘病变的手术治疗。随访时间为1至60个月。所有病例均按照卡斯帕法进行了显微椎间盘切除术;对于有不稳定证据的病例以及创伤后椎间盘突出症患者,进行了前路稳定手术。

结果

共使用了119个高度为4至8毫米的碳纤维椎间融合器以及10个带螺钉的前路钢板。用于填充椎间融合器的材料类型为同种异体骨(50.5%)、异种异体骨(22.3%)、羟基磷灰石(21.1%)和自体骨(6%)。所有病例在至少6个月后进行的随访X线片均显示骨融合。没有患者出现植入物自发移位或神经受压症状。

结论

这些初步结果表明,颈椎前路使用碳纤维椎间融合器进行融合对于恢复椎间盘高度和促进骨融合是有效的,且并发症发生率较低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验